Among the key drivers of OSCC progression, the overexpression of epidermal growth factor receptor (EGFR) has been strongly linked to enhanced tumor growth, invasion, and resistance to therapy [[8], [9], [10], [11]]. Here, EGFR is linked to neoplasm.